NysnoBio Awarded Michael J. Fox Foundation Grant to Advance Parkin Gene Therapy
July 17, 2023 16:05 ET | NysnoBio LLC
- The funding will support NB001 Parkin gene replacement therapy IND-enabling studies- Initial indication in a substantial, genetically defined Parkinson’s population: Parkin-PD- Parkin-PD mutations...